Icosavax, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q3 2023.

Location
Seattle, WA
Fiscal year end
31 December
Latest financial report
14 Nov 2023

Quick Takeaways

  • Icosavax, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q3 2023.
  • Headline metric: Return On Equity -42%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+27%</span>.
  • Most recent SEC facts end date: 08 Nov 2023.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2023-11-08) highlights Return On Equity -42.2%, Return On Assets -39.1%, and Current Ratio 18.06x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

19.9/100

Weak Confidence medium

Return On Equity

-42%

Metric score 0.0/100

Return On Assets

-39%

Metric score 0.0/100

Financial Health

Current Ratio
18.06x
Debt to Equity
0.09x

Strengths

Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Current Ratio

Key metrics snapshot

Return On Equity

-42%

YoY: +27%

Industry median: -47% (n=218)

View history

Return On Assets

-39%

YoY: +23%

Industry median: -44% (n=217)

View history

Current Ratio

18.06x

YoY: +2.9%

Industry median: 3.67x (n=218)

View history

Debt-to-equity

0.09x

YoY: +45%

Industry median: 0.31x (n=169)

View history

NetIncomeLoss YoY

-12%

YoY:

Industry median: -12% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity -42% +27%
Return On Assets -39% +23%

Financial Health

Metric Latest value YoY change
Current Ratio 18.06x +2.9%
Debt-to-equity 0.09x +45%

Growth

Metric Latest value YoY change
NetIncomeLoss YoY -12%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 50,090,341 +26%
Common Stock, Shares, Outstanding 50,088,633 +26%
Common Stock, Value, Issued $7,000 +40%
Weighted Average Number of Shares Outstanding, Basic 50,030,759 +26%
Weighted Average Number of Shares Outstanding, Diluted 50,030,759 +26%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $70,044,000 +11%
General and Administrative Expense $35,839,000 +30%
Operating Income (Loss) $105,883,000 -20%
Nonoperating Income (Expense) $9,171,000 +406%
Earnings Per Share, Basic -2 +20%
Earnings Per Share, Diluted -2 +20%
Cash, Cash Equivalents, and Short-term Investments $229,200,000
Assets, Current $235,307,000 +2.9%
Property, Plant and Equipment, Net $11,400,000 -3.5%
Operating Lease, Right-of-Use Asset $2,975,000 -11%
Other Assets, Noncurrent $1,614,000
Assets $251,296,000 +3%
Accrued Liabilities, Current $9,606,000 +43%
Liabilities, Current $13,030,000 -0.02%
Operating Lease, Liability, Noncurrent $5,886,000 +16%
Other Liabilities, Noncurrent $0 -100%
Liabilities $18,916,000 +3.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax $48,000 +92%
Retained Earnings (Accumulated Deficit) $258,926,000 -60%
Stockholders' Equity Attributable to Parent $232,380,000 +3%
Liabilities and Equity $251,296,000 +3%
Common Stock, Shares Authorized 500,000,000 0%
Common Stock, Shares, Issued 50,088,633 +26%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $63,239,000 -3.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 0%
Operating Lease, Liability $8,071,000 +21%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $96,151,000 +1.3%
Operating Lease, Liability, Current $2,185,000 +37%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,201,000 +3%
Lessee, Operating Lease, Liability, to be Paid, Year One $365,000
Operating Lease, Weighted Average Discount Rate, Percent 0.08 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9,573,000 -16%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,267,000 +3%
Preferred Stock, Shares Authorized 50,000,000
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,335,000 +3%
Additional Paid in Capital $491,347,000 +26%
Preferred Stock, Shares Outstanding 0
Share-based Payment Arrangement, Expense $25,071,000 +30%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY